#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer Gaucher's disease type III Synovial sarcoma metastatic Infantile apnoea Postprandial hypoglycaemia Follicular lymphoma stage II Pyoderma gangrenosum B-cell lymphoma Frontotemporal dementia Biotinidase deficiency Nephropathy Nodal marginal zone B-cell lymphoma Cerebral haemorrhage Burkitt's lymphoma refractory Pyruvate kinase deficiency anaemia More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma – Treatment KBG syndrome – Life with Disease Brain stem glioma – Trials in Disease Wiskott-Aldrich syndrome – Treatment Progressive supranuclear palsy – Trials in Disease Biotinidase deficiency – Life with Disease Toxic epidermal necrolysis Glycogen storage disease type V – Basic Information Myxofibrosarcoma – Trials in Disease Paraneoplastic neurological syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RIVASTIGMINE Phleum Pratense Asparaginase Progesterone, Micronised Eye103 Pioglitazone Hydrochloride Ataluren Bemarituzumab Cloxacillin Sodium AMODIAQUINE Zanidatamab Motixafortide Pf-07220060 Monohydrate Df6002 Inotuzumab Ozogamicin Dexamethasone Ph. Eur. Topotecan Imipenem Monohydrate L-Glutamic Acid Incb099280 More therapies…

    Learn about Your Condition

    Retinoblastoma Metabolic surgery Arterial stiffness Papillary thyroid cancer Premature rupture of membranes Benign prostatic hyperplasia Clostridium difficile colitis Oesophageal carcinoma Intestinal ischaemia Asthmatic crisis Haemorrhage prophylaxis Vulval cancer recurrent Erythema migrans Pyoderma Biotinidase deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Serum Transthyretin Levels in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis and Acoramidis: A Within‑Patient Pilot Crossover Study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Tafamidis
    • Acoramidis
    Austria

  • Efficacy and Safety of Daily Subcutaneous Elamipretide Trihydrochloride Injections in Patients with Barth Syndrome (Phase 3b/4 Randomized Trial)

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Elamipretide Trihydrochloride
    France Ireland Italy The Netherlands

  • Safety and feasibility study of CARCIK‑CD123/33 cell therapy in adult and pediatric patients with relapsed or refractory AML and BPDCN

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Blastic plasmacytoid dendritic cell neoplasia
    • Acute myeloid leukaemia
    Italy

  • Intrapleural Alteplase and Dornase Alfa versus VATS for Patients with Pleural Empyema (Parapneumonic Pleural Infection)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dornase Alfa
    • Alteplase
    The Netherlands

  • Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Apixaban
    Finland

  • Safety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Rbd4059
    • Apixaban
    Denmark Norway Poland Sweden
Previous Page
1 … 672 673 674 675 676 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!